English | 繁體

Search in the results

UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
TGFβ2-mediated epithelial-mesenchymal transition and NF-κB pathway activation contribute to osimertinib resistance Journal article
Jiang, XM, Xu, YL, Yuan, LW, Zhang, LL, Huang, MY, Ye, ZH, Su, MX, Chen, X. P., Zhu, H, Ye, R, Lu, J.. TGFβ2-mediated epithelial-mesenchymal transition and NF-κB pathway activation contribute to osimertinib resistance[J]. Acta Pharmacologica Sinica, 2020, 451-459.
Authors:  Jiang, XM;  Xu, YL;  Yuan, LW;  Zhang, LL;  Huang, MY; et al.
Favorite |  | Submit date：2022/08/26
Egfr Mutant Non-small Cell Lung Cancer  Nf-κb  Tgfβ2  Epithelial-mesenchymal Transition  Osimertinib Resistance  
Simultaneous quantification six active compounds in rat plasma by UPLC–MS/MS and its application to a pharmacokinetic study of Pien-Tze- Huang Journal article
Xu, W, Zhang, YP, Zhou, CJ, Tai, YN, Zhang, XQ, Liu, J, Sha, M, Huang, MQ, Zhu, YL, Peng, J, Lu, J.. Simultaneous quantification six active compounds in rat plasma by UPLC–MS/MS and its application to a pharmacokinetic study of Pien-Tze- Huang[J]. Journal of Chromatography B, 2017, 314-321.
Authors:  Xu, W;  Zhang, YP;  Zhou, CJ;  Tai, YN;  Zhang, XQ; et al.
Favorite |   IF:2.8/2.8 | Submit date：2022/03/31
Pian-tze-huang  Uplc–ms/ms  Ginsenosides  Muscone  Pharmacokinetics